JohnDanielCarterMD

PubMed

• Chlamydia trachomatis is present and metabolically active during the remitting phase in synovial tissues from patients with chronic Chlamydia-induced reactive arthritis.
  Gérard, H. C.,Carter, J. D.,Hudson, A. P.> ;Am. J. Med. Sci.. 2013 Jul
• Attack Rate of Chlamydia-induced Reactive Arthritis and Effect of the CCR5-Delta-32 Mutation: A Prospective Analysis.
  Carter, J. D.,Rehman, A.,Guthrie, J. P.,Gerard, H. C.,Stanich, J.,Hudson, A. P.> ;J. Rheumatol.. 2013 Sep
• Chlamydia trachomatis Is Present and Metabolically Active During the Remitting Phase in Synovial Tissues From Patients With Chronic Chlamydia-Induced Reactive Arthritis.
  Gérard, H. C.,Carter, J. D.,Hudson, A. P.> ;Am J Med Sci. 2013 Jan 16
• The molecular basis for disease phenotype in chronic Chlamydia-induced arthritis.
  Carter, J. D.,Gerard, H. C.,Whittum-Hudson, J. A.,Hudson, A. P.> ;Int J Clin Rheumtol. 2012 Dec 1
• Chlamydia and chronic arthritis.
  Carter, J.D., Inman, R.D., Whittum-Hudson, J., Hudson, A.P.> ;Ann Med. 2012 Dec
• Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight?
  Carter, J. D., Gérard, H. C., Whittum-Hudson, J. A., Hudson, A. P.> ;Int J Clin Rheumtol. 2011 Jun
• Virtual rheumatology: using simulators and a formal workshop to teach medical students, internal medicine residents, and rheumatology subspecialty residents arthrocent...
  Sterrett, A.G., Bateman, H., Guthrie, J., Rehman, A., Osting, V., Carter, J.D., Ricca, L., Valeriano-Marcet, J.> ;J Clin Rheumatol. 2011 Apr
• Functional CCR5 receptor protects patients with arthritis from high synovial burden of infecting Chlamydia trachomatis.
  Gérard, H. C., Stanich, J. A., Oszust, C. E., Whittum-Hudson, J. A., Carter, J. D., Schumacher, H. R., Hudson, A. P.> ;Am J Med Sci. 2010 Dec
• The pathogenic role of Chlamydia in spondyloarthritis.
  Gérard, H.C., Whittum-Hudson, J.A., Carter, J.D., Hudson, A.P.> ;Curr Opin Rheumatol. 2010 Jul
• The evolving story of Chlamydia-induced reactive arthritis.
  Carter, J.D., Hudson, A.P.> ;Curr Opin Rheumatol. 2010 Jul
• Atypical insufficiency fracture of the tibia associated with long-term bisphosphonate therapy.
  Breglia, M.D., Carter, J.D.> ;J Clin Rheumatol. 2010 Mar
• Are inflammatory bowel disease (IBD) and pouchitis a reactive enteropathy to group D streptococci (Enterococci)?
  Ingram, S., McKinley, J.M., Vasey, F., Carter, J.D., Brady, P.G.> ;Inflamm Bowel Dis. 2009-11-01
• Successful treatment of pemphigus vulgaris with etanercept in four patients.
  Shetty, A., Marcum, C.B., Glass, L.F., Carter, J.D.> ;J Drugs Dermatol. 2009-10-01
• Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis.
  Carter, J. D., Gérard, H. C., Espinoza, L. R., Ricca, L. R., Valeriano, J., Snelgrove, J., Oszust, C., Vasey, F. B., Hudson, A. P.> ;Arthritis Rheum. 2009-05-01
• Granulomatosis with CNS involvement: a neuroimaging clinicopathologic correlation.
  Baaj, A.A., Vale, F.L., Carter, J.D., Rojiani, A.M.> ;J Neuroimaging. 2009 Apr
• Molecular biology of infectious agents in chronic arthritis.
  Gérard, H. C., Whittum-Hudson, J. A., Carter, J. D., Hudson, A. P.> ;Rheum Dis Clin North Am. 2009-02-01
• Reactive arthritis: clinical aspects and medical management.
  Carter, J.D., Hudson, A.P.> ;Rheum Dis Clin North Am. 2009-02-01
• Oxidative reactivity difference among the metal oxo and metal hydroxo moieties: pH dependent hydrogen abstraction by a manganese(IV) complex having two hydroxide ligands.
  Yin, G., Danby, A.M., Kitko, D., Carter, J.D., Scheper, W.M., Busch, D.H.> ;J Am Chem Soc. 2008-12-03
• Urticarial vasculitis.
  Brown, N.A., Carter, J.D.> ;Curr Rheumatol Rep. 2007 Aug
• Olefin epoxidation by alkyl hydroperoxide with a novel cross-bridged cyclam manganese complex: demonstration of oxygenation by two distinct reactive intermediates.
  Yin, G., Danby, A.M., Kitko, D., Carter, J.D., Scheper, W.M., Busch, D.H.> ;Inorg Chem. 2007 Mar 19
• Understanding the selectivity of a moderate oxidation catalyst: hydrogen abstraction by a fully characterized, activated catalyst, the robust dihydroxo manganese(IV) c...
  Yin, G., Danby, A.M., Kitko, D., Carter, J.D., Scheper, W.M., Busch, D.H.> ;J Am Chem Soc. 2007 Feb 14
• Reactive arthritis: defined etiologies, emerging pathophysiology, and unresolved treatment.
  Carter, J.D.> ;Infect Dis Clin North Am. 2006 Dec
• Synthesis, characterization, and solution properties of a novel cross-bridged cyclam manganese(IV) complex having two terminal hydroxo ligands.
  Yin, G., McCormick, J.M., Buchalova, M., Danby, A.M., Rodgers, K., Day, V.W., Smith, K., Perkins, C.M., Kitko, D., Carter, J.D., Scheper, W.M., Busch, D.H.> ;Inorg Chem. 2006 Oct 2
• Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men.
  Cruse, L.M., Valeriano, J., Vasey, F.B., Carter, J.D.> ;J Clin Rheumatol. 2006 Oct
• Hydroxychloroquine as a treatment for atrophoderma of Pasini and Pierini.
  Carter, J.D., Valeriano, J., Vasey, F.B.> ;Int J Dermatol. 2006 Oct
• Join now to see all